A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation.

A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation. Ann Surg. 2011 Feb; 253(2):328-35.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antigens, Neoplasm
Cancer Vaccines
Carcinoma, Pancreatic Ductal
Cell Line, Tumor
Combined Modality Therapy
Disease-Free Survival
Female
GPI-Linked Proteins
Granulocyte-Macrophage Colony-Stimulating Factor
Humans
Hypersensitivity, Delayed
Immunotherapy
Male
Middle Aged
Pancreatic Neoplasms
Survival Rate
T-Lymphocytes
Transfection

authors with profiles

Ross Abrams